Oxford Genetics is a leading synthetic biology company focused on developing novel technologies to overcome the challenges associated with the discovery, development and production of biologics, gene therapies, cell therapies and vaccines.
Our proprietary genomic system enables the precise engineering of DNA, which in combination with our automated platforms, drive the rational design of complex biologics and their associated production processes. With the overarching aim of increasing predictability, robustness and scalability, while lowering cost and human error.
At Oxford Genetics, ambition and optimism runs through everything we do. Our company was founded on the belief that there was a better way to create biologics. That pioneering spirit is in our DNA and continues to drive us today. We don’t just develop the best products and technologies for our customers, but also provide the best facilities and environments for our employees.